Who is sponsoring NCT04954391?

NCT04954391 is sponsored by Saint Petersburg State University, Russia.

What drugs are being tested in NCT04954391?

Interventions in NCT04954391: Pulsed radiofrequency neuromodulation of the suprascapular nerve only, Pulsed radiofrequency neuromodulation of the suprascapular, axillary, and articular branch of the lateral pectoral nerves.

What condition does NCT04954391 study?

NCT04954391 studies Chronic Shoulder Pain.

Is NCT04954391 still recruiting?

NCT04954391 is currently status unknown. Last updated 23 May 2023.

Last reviewed 2023-05-23 · How we verify

NCT04954391

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulsed Radiofrequency One or Three Nerves for Chronic Shoulder Pain. A Prospective, Randomized, Double-blind Study

Status unknown NA Last updated 23 May 2023

What this trial tests

NA trial testing Pulsed radiofrequency neuromodulation of the suprascapular nerve only in Chronic Shoulder Pain in 142 participants. Status unknown.

Timeline

5 August 2021

Primary endpoint
30 December 2023

30 April 2024

Quick facts

Lead sponsor	Saint Petersburg State University, Russia
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	142
Start date	5 August 2021
Primary completion	30 December 2023
Estimated completion	30 April 2024
Sites	1 location across Russia

Drugs / interventions tested

Pulsed radiofrequency neuromodulation of the suprascapular nerve only
Pulsed radiofrequency neuromodulation of the suprascapular, axillary, and articular branch of the lateral pectoral nerves

Conditions studied

Chronic Shoulder Pain — all drugs for Chronic Shoulder Pain →

Sponsor

Saint Petersburg State University, Russia

Who can join

Adults 18 to 99, any sex, with Chronic Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pulsed radiofrequency (PRF) neuromodulation / or ablation is an interventional pain management method. Clinical use of PRF for shoulder pain management generally focuses on the suprascapular nerve, what is considered a safe and superior to placebo and physiotherapy. We study the use of the PRF neuromodulation the suprascapular, axillary, and articular branches of the lateral pectoral nerve, as well as the effectiveness of this combined technique compared to the PRF of the suprascapular nerve alone

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Shoulder Pain

Currently open trials in the same condition.

NCT06661681 — Cognitive Functional Therapy for Treating Individuals With Chronic Shoulder Pain · NA · recruiting
NCT06542666 — Cognitive Functional Therapy for Chronic Shoulder Pain: Pilot and Feasibility Study · NA · recruiting
NCT05754190 — Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA · recruiting

Other Saint Petersburg State University, Russia trials

Trials by the same sponsor.

NCT07116343 — Intrapleural Ropivacaine Infusion in Cardiac Surgery · Phase 4 · recruiting
NCT07185334 — Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating · NA · active not recruiting
NCT07106112 — Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy · NA · recruiting
NCT06654401 — Electrical Cardioversion As a Predictor in Postoperative Preservation of Sinus Rhythm · NA · recruiting
NCT06626711 — Effect of Propofol and Sevoflurane Anesthesia on HSP70 Expression in Tumor Cells · EARLY_PHASE1 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04954391 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saint Petersburg State University, Russia
Last refreshed: 23 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04954391.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing